Announcements Trials
Browse Landscape

Phase

Phase NA 32Phase 4 3Phase 3 3Phase 2/3 3Phase 2 3Phase 1/2 2

Status

Recruiting 4Unknown 3Completed 2Withdrawn 1Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Stomach Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Liver Neoplasms 1Hemorrhage 1Glioblastoma 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Standard of Care × Clear all
NCT03548571 2024-04-03

DEN-STEM

Oslo University Hospital

Phase 2/3 Unknown
60 enrolled
CNS

Glioblastoma

NCT02759783 2019-08-21

CORE

Royal Marsden NHS Foundation Trust

Phase 2/3 Unknown
245 enrolled
BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms

NCT01655641 2012-10-16

TMGS

Tribhuvan University Teaching Hospital, Institute Of Medicine.

Phase 2/3 Unknown
118 enrolled
Gastrointestinal

Colonic Neoplasms, Hemorrhage, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡